Latest Past Events

New Approval for Metastatic Breast Cancer: Alpelisib

This past May, the FDA approved the targeted therapy alpelisib (Piqray) to treat certain hormone receptor-positive, HER2-negative breast cancers in postmenopausal women and in men. Up to 40 percent of people with metastatic hormone receptor-positive, HER2-negative breast cancer could be eligible to get the treatment, which targets a mutation on the PIK3CA gene. Join us... Continue Reading →

Genomics and Genetics: What is the Difference?

Topics Covered Definition of Genetics & Genomics The Importance of Genetic & Genomic Testing The Value of Early Testing to Inform Your Treatment Choices Their Role in Selecting Your Cancer Treatment Understanding Types of Gene Mutations The Difference Between Inherited & Acquired or Sporadic Gene Mutations The Role of the Pathologist How Genomic Testing Drives... Continue Reading →

Up ↑